sever
acut
respiratori
syndrom
pathogen
respons
atyp
pneumonia
affect
peopl
caus
death
patient
march
report
coronaviru
spike
glycoprotein
mediat
entri
cell
end
predominantli
lung
epitheli
alveolar
cell
precipit
interstiti
pneumonia
evolv
acut
respiratori
distress
syndrom
ard
interestingli
acut
kidney
injuri
aki
occurr
report
clinic
set
data
recent
confirm
italian
report
istituto
superior
di
describ
incid
patient
updat
march
http
commentari
discuss
possibl
mechan
aki
indic
potenti
new
approach
risk
stratif
infect
patient
may
help
clinic
decis
emerg
scenario
aki
repres
lifethreaten
complic
critic
ill
patient
often
lead
increas
risk
death
recent
report
wilson
et
al
onset
moderatetosever
aki
describ
higherrisk
subset
ard
patient
signific
risk
mortal
consid
possibl
pathogen
mechan
akiassoci
ard
aki
may
ascrib
differ
caus
impair
ga
exchang
hemodynam
alter
includ
right
heart
failur
fluid
overload
system
congest
injuri
mechan
ventil
strategi
develop
secondari
infectionssepsi
sever
studi
emphas
relev
inflammatoryimmunemedi
reaction
releas
high
level
circul
harm
mediat
capabl
interact
kidneyresid
cell
caus
endotheli
dysfunct
microcirculatori
derang
tubular
injuri
accord
previou
studi
beta
coronavirus
sarscov
recent
use
angiotensinconvert
enzym
receptor
facilit
viral
entri
target
cell
also
locat
surfac
kidney
tubular
cell
infect
may
worsen
local
inflammatori
respons
consequ
incid
durat
aki
episod
tabl
describ
aki
develop
averag
day
admiss
togeth
secondari
infect
acut
cardiac
damag
age
sever
ill
presenc
diabet
risk
factor
aki
ard
patient
moreov
sever
aki
associ
bmi
histori
heart
failur
also
defin
cardioren
syndrom
similar
observ
includ
presenc
diabet
report
ard
risk
factor
ad
increas
incid
aki
elderli
lead
hypothesi
renal
complic
predomin
patient
preexist
chronic
impair
kidney
function
difficult
evalu
base
serum
creatinin
level
thu
claim
use
new
biomark
earli
kidney
injuri
therefor
determin
risk
develop
aki
infect
patient
progress
sever
aki
requir
renal
replac
therapi
import
step
patient
prognosi
earli
implement
prevent
protect
measur
classic
assess
aki
still
base
serum
creatinin
urin
output
repres
indic
establish
kidney
damag
scenario
much
attent
focus
novel
biomark
last
year
particularli
marker
acut
tubular
stressdamag
tissu
inhibitor
metalloproteinas
insulinlik
growth
factor
bind
protein
product
identifi
use
nephrocheck
test
test
set
predict
moder
sever
aki
within
h
icu
admiss
one
approv
food
drug
administr
set
sever
evid
suggest
applic
nephrocheck
may
help
physician
identifi
patient
tubular
stress
kidney
dysfunct
manifest
critic
ill
patient
inde
expos
sever
potenti
kidney
insult
set
infect
drug
nephrotox
contrast
media
icu
stay
serial
measur
biomark
may
use
tool
predict
aki
first
day
icu
stay
posit
test
suggest
high
risk
develop
aki
may
requir
earli
nephrolog
consult
close
monitor
creatinin
urin
output
optim
volum
hemodynam
statu
avoid
iodin
contrast
procedur
possibl
use
nephrotox
drug
eg
aminoglycosid
ace
inhibitor
nsaid
close
monitor
drug
level
vancomycin
ard
patient
develop
aki
higher
risk
sever
outcom
mortal
opinion
compel
establish
predict
model
stratifi
infect
patient
accord
aki
sever
approach
might
lead
innov
biomarkerbas
intervent
strategi
emerg
clinic
contest
lead
better
alloc
hospit
resourc
tabl
key
point
acut
kidney
injuri
infect
patient
aki
frequent
observ
ard
patient
affect
differ
comorbid
similar
find
observ
wuhan
infect
patient
ardsassoci
aki
may
ascrib
sever
caus
includ
inflammatoryimmun
reaction
character
enhanc
releas
circul
mediat
abl
interact
damag
kidneyresid
cell
kidney
epitheli
cell
viral
infect
may
worsen
local
inflammatori
respons
consequ
incid
durat
aki
episod
comorbid
may
associ
preexist
chronic
declin
kidney
function
concept
renal
function
reserv
tendenc
develop
aki
episod
identif
patient
aki
may
lead
better
alloc
hospit
resourc
earli
biomark
aki
may
favor
process
use
extracorpor
blood
purif
techniqu
antivir
therapi
may
theoret
limit
system
local
inflammatori
respons
least
part
respons
multipl
organ
failur
includ
aki
